InvestorsHub Logo
icon url

efar

10/28/10 1:06 AM

#107364 RE: DewDiligence #107360

Seems as though Teva's whisperings about a September FDA inspection could explain some of the short interest / near term puts, but given the evidence I don't see how t-Enoxaparin approval is possible.